Reuters logo
BRIEF-Xvivo Perfusion Q4 adjusted EBITDA drops to SEK 6.7 mln
February 8, 2017 / 7:58 AM / 8 months ago

BRIEF-Xvivo Perfusion Q4 adjusted EBITDA drops to SEK 6.7 mln

Feb 8 (Reuters) - Xvivo Perfusion Ab:

* Q4 sales 38.4 million Swedish crowns ($4.32 million) versus 32.7 million crowns year ago

* Q4 adjusted EBITDA 6.7 million crowns versus 7.2 million crowns year ago Source text for Eikon: Further company coverage: ($1 = 8.8803 Swedish crowns) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below